Top-News
Pharmazeutika Luxemburg

Alvotech SA News

Aktie
WKN:  A3DK8U ISIN:  LU2458332611 US-Symbol:  ALVO
10,15 €
-0,05 €
-0,49%
06.09.24
Handeln Depot/Watchlist
Aktienanzahl *
267,25 Mio.
Marktkapitalisierung *
2,67 Mrd. €
Streubesitz
30,63%
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 13.03.2024

Alvotech SA News

17.07.23 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alvotech SA - ALVO
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alvotech SA - ALVO PR Newswire
12.07.23 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alvotech SA - ALVO
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alvotech SA - ALVO PR Newswire
14.06.23 - PR Newswire
ALVO, ALVOW INVESTOR NEWS: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVO, ALVOW
ALVO, ALVOW INVESTOR NEWS: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVO, ALVOW ...
26.05.23 - PR Newswire
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVOW
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVOW PR Newswire
10.05.23 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alvotech - ALVO
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alvotech - ALVO PR Newswire
02.05.23 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alvotech - ALVO
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alvotech - ALVO PR Newswire
19.04.23 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alvotech - ALVO
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alvotech - ALVO PR Newswire
19.10.22 - PR Newswire
Alvotech and JAMP Pharma Expand Exclusive Partnership Adding Two Biosimilar Candidates for Canadian Market, Bringing New Options for Patients in Specialty Care
Alvotech and JAMP Pharma Expand Exclusive Partnership Adding Two Biosimilar Candidates for Canadian Market, Bringing New Options for Patients in Specialty Care Canada ...

Newssuche

Videos

newspaper
04.09.24 -9,76%
Technical Trading: Zucker Long kurzfristig
Sugar Long Typ: Turbo Open End WKN: VV50DP Hebel: 5,06 Laufzeit: OpenEnd Einstieg: Market ... Mehr »